Jacobs Levy Equity Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$761K	Buy	+169,144	New	+$676K	﹤0.01%	760
2019 Q4	–	Sell	-22,170	Closed	-$197K	–	1036
2019 Q3	$197K	Buy	22,170 +7,375	+50%	+$80.9K	﹤0.01%	846
2019 Q2	$211K	Buy	14,795 +9,217	+165%	+$246K	﹤0.01%	872
2019 Q1	$183K	Buy	5,578 +1,434	+35%	+$73.5K	﹤0.01%	906
2018 Q4	$246K	Sell	4,144 -3,930	-49%	-$388K	﹤0.01%	842
2018 Q3	$1.13M	Sell	8,074 -217	-3%	-$26.3K	0.02%	629
2018 Q2	$1.02M	Buy	8,291 +4,494	+118%	+$382K	0.02%	661
2018 Q1	$339K	Sell	3,797 -567	-13%	-$48.1K	0.01%	845
2017 Q4	$242K	Sell	4,364 -676	-13%	-$30.5K	﹤0.01%	873
2017 Q3	$213K	Buy	5,040 +508	+11%	+$21.1K	﹤0.01%	849
2017 Q2	$191K	Buy	4,532 +3,100	+216%	+$159K	﹤0.01%	850
2017 Q1	$80K	Sell	1,432 -1,001	-41%	-$49.7K	﹤0.01%	871
2016 Q4	$93K	Buy	+2,433	New	+$98.7K	﹤0.01%	910